Literature for inhibitor I04.024: C1 inhibitor

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: S Structure, M Mutation, I Inhibitor, K Knockout, E Expression, V Review, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

2026

No,a.l. C1 Esterase Inhibitor (2026) PubMed Europe PubMed

2025

Bernstein,J.A., Cheng,J., Pisani,T., Sexton,D., Whitaker,R.E., Nova Estepan,D. and Inhaber,N. Clinical validity of dried blood spot assay for the measurement of functional C1 inhibitor in angioedema due to C1 inhibitor deficiency J Allergy Clin Immunol Glob (2025) 4, 100401-100401. PubMed Europe PubMed DOI PMC EPMC
Ren,Z., Bao,J., Zhao,S., Pozzi,N., Wedner,H. and Atkinson,J.P. N-glycosylation in the SERPIN domain of C1-Esterase Inhibitor in hereditary angioedema JCI Insight (2025) PubMed Europe PubMed DOI
Shen,Y., Dong,X., Li,X., Shi,Z., Shao,T., Jiang,J. and Song,J. WNT inhibitor SP5-mediated SERPING1 suppresses lung adenocarcinoma progression via TSC2/mTOR pathway Cell Death Dis (2025) 16, 103-103. PubMed Europe PubMed DOI PMC EPMC

2024

Garrigues,R.J., Garrison,M.P. and Garcia,B.L. The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation J Immunol (2024) 213, 718-729. PubMed Europe PubMed DOI
Riedl,M.A., Bordone,L., Revenko,A., Newman,K.B. and Cohn,D.M. Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema J Allergy Clin Immunol Pract (2024) 12, 911-918. PubMed Europe PubMed DOI K

2023

[YEAR:15-8-2023] C1 Esterase Inhibitor (15-8-2023) PubMed Europe PubMed
Miyata,T. and Horiuchi,T. Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency Allergol Int (2023) 72, 375-384. PubMed Europe PubMed DOI

2022

Al-Kuraishy,H.M., Al-Gareeb,A.I., Jalal,N.A., Kabrah,S.M., Alexiou,A. and Batiha,G.E. SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective Curr Protein Pept Sci (2022) 23, 465-474. PubMed Europe PubMed DOI
Alfaro,E., Diaz-Garcia,E., Garcia-Tovar,S., Zamarron,E., Mangas,A., Galera,R., Nanwani-Nanwani,K., Perez-de-Diego,R., Lopez-Collazo,E., Garcia-Rio,F. and Cubillos-Zapata,C. Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity Front Immunol (2022) 13, 909342-909342. PubMed Europe PubMed DOI PMC EPMC
Gramstad,O.R., Kandanur,S.P.S., Etscheid,M., Nielsen,E.W. and Kanse,S.M. Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency Mol Immunol (2022) 142, 95-104. PubMed Europe PubMed DOI
Hurler,L., Toonen,E.J.M., Kajdacsi,E., van Bree,B., Brandwijk,R.J.M.G., de Bruin,W., Lyons,P.A., Bergamaschi,L., Sinkovits,G., Cervenak,L., Wurzner,R. and Prohaszka,Z. Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs Front Immunol (2022) 13, 1039765-1039765. PubMed Europe PubMed DOI PMC EPMC

2021

Karnaukhova,E. C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development Curr Med Chem (2021) PubMed Europe PubMed DOI

2020

Hor,L., Pan,J., Whisstock,J.C., Pike,R.N. and Wijeyewickrema,L.C. Mapping the binding site of C1-inhibitor for polyanion cofactors Mol Immunol (2020) 126, 8-13. PubMed Europe PubMed DOI
Marceau,F., Rivard,G.E., Gauthier,J.M., Binkley,K.E., Bonnefoy,A., Boccon-Gibod,I., Bouillet,L., Picard,M., Levesque,G., Elfassy,H.L., Bachelard,H., Hebert,J. and Bork,K. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants Front Med (Lausanne) (2020) 7, 358-358. PubMed Europe PubMed DOI PMC EPMC I
Ponard,D., Gaboriaud,C., Charignon,D., Ghannam,A., Wagenaar-Bos,I.G.A., Roem,D., Lopez-Lera,A., Lopez-Trascasa,M., Tosi,M. and Drouet,C. SERPING1 mutation update: mutation spectrum and C1 inhibitor phenotypes Hum Mutat (2020) 41, 38-57. PubMed Europe PubMed DOI M
Verbree-Willemsen,L., Zhang,Y.N., Ibrahim,I., Ooi,S.B.S., Wang,J.W., Mazlan,M.I., Kuan,W.S., Chan,S.P., Peelen,L.M., Grobbee,D.E., Richards,A.M., Lam,C.S.P. and de Kleijn,D.P.V. Extracellular vesicle Cystatin C and CD14 are associated with both renal dysfunction and heart failure ESC Heart Fail (2020) 7, 2240-2249. PubMed Europe PubMed DOI

2019

Wong,W.Y., Wong,H., Au,E. and Chan,E. Identification and mapping of a 2,009-bp DNA deletion in SERPING1 of a hereditary angioedema patient Case Rep Genet (2019) 2019, 7052062-7052062. PubMed Europe PubMed DOI PMC EPMC M

2018

Aygoren-Pursun,E., Bygum,A., Grivcheva-Panovska,V., Magerl,M., Graff,J., Steiner,U.C., Fain,O., Huissoon,A., Kinaciyan,T., Farkas,H., Lleonart,R., Longhurst,H.J., Rae,W., Triggiani,M., Aberer,W., Cancian,M., Zanichelli,A., Smith,W.B., Baeza,M.L., Du-Thanh,A., Gompels,M., Gonzalez-Quevedo,T., Greve,J., Guilarte,M., Katelaris,C., Dobo,S., Cornpropst,M., Clemons,D., Fang,L., Collis,P., Sheridan,W., Maurer,M. and Cicardi,M. Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema N Engl J Med (2018) 379, 352-362. PubMed Europe PubMed DOI I
Caccia,S., Suffritti,C., Carzaniga,T., Berardelli,R., Berra,S., Martorana,V., Fra,A., Drouet,C. and Cicardi,M. Intermittent C1-inhibitor deficiency associated with recessive inheritance: functional and structural insight Sci Rep (2018) 8, 977-977. PubMed Europe PubMed DOI PMC EPMC M
Hovingh,E.S., de Maat,S., Cloherty,A.P.M., Johnson,S., Pinelli,E., Maas,C. and Jongerius,I. Virulence associated gene 8 of Bordetella pertussis enhances contact system activity by inhibiting the regulatory function of complement regulator C1 inhibitor Front Immunol (2018) 9, 1172-1172. PubMed Europe PubMed DOI PMC EPMC
Nilojan,J., Bathige,S.D.N.K., Thulasitha,W.S., Kwon,H., Jung,S., Kim,M.J., Nam,B.H. and Lee,J. Transcriptional profiling, molecular cloning, and functional analysis of C1 inhibitor, the main regulator of the complement system in black rockfish, Sebastes schlegelii Fish Shellfish Immunol (2018) 75, 263-273. PubMed Europe PubMed DOI

2017

Ding,M., Chen,M., Zhong,X., Wang,Y., Fu,S., Yin,X., Guo,Z. and Ye,J. Identification and characterization of C1 inhibitor in Nile tilapia (Oreochromis niloticus) in response to pathogenic bacteria Fish Shellfish Immunol (2017) 61, 152-162. PubMed Europe PubMed DOI
Longhurst,H.J. Kallikrein inhibition for hereditary angioedema N Engl J Med (2017) 376, 788-789. PubMed Europe PubMed DOI

2016

Dijk,M., Holkers,J., Voskamp,P., Giannetti,B.M., Waterreus,W.J., van Veen,H.A. and Pannu,N.S. How dextran sulfate affects C1-inhibitor activity: a model for polysaccharide potentiation Structure (2016) 24, 2182-2189. PubMed Europe PubMed DOI S
Ghannam,A., Sellier,P., Fain,O., Martin,L., Ponard,D. and Drouet,C. C1 Inhibitor as a glycoprotein: the influence of polysaccharides on its function and autoantibody target Mol Immunol (2016) 71, 161-165. PubMed Europe PubMed DOI
Hermanrud,T., Duus,N., Bygum,A. and Rasmussen,E.R. The use of plasma-derived complement C1-esterase inhibitor concentrate (Berinert(R)) in the treatment of angiotensin converting enzyme-inhibitor related angioedema Case Rep Emerg Med (2016) 2016, 3930923-3930923. PubMed Europe PubMed DOI PMC EPMC U

2015

Lipski,S.M., Casimir,G., Vanlommel,M., Jeanmaire,M. and Dolhen,P. Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert(R)): about one case and review of the therapeutic arsenal Clin Case Rep (2015) 3, 126-130. PubMed Europe PubMed DOI PMC EPMC U
Madsen,D.E., Sidelmann,J.J., Biltoft,D., Gram,J. and Hansen,S. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: implication for a role in hereditary angioedema Biochim Biophys Acta (2015) 1850, 1336-1342. PubMed Europe PubMed DOI

2014

Kumar,A., Bhandari,A., Sarde,S.J. and Goswami,C. Molecular phylogeny of C1 inhibitor depicts two immunoglobulin-like domains fusion in fishes and ray-finned fishes specific intron insertion after separation from zebrafish Biochem Biophys Res Commun (2014) 450, 219-226. PubMed Europe PubMed DOI
Tradtrantip,L., Asavapanumas,N., Phuan,P.W. and Verkman,A.S. Potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model PLoS ONE (2014) 9, e106824-e106824. PubMed Europe PubMed DOI PMC EPMC
Umasuthan,N., Bathige,S.D., Revathy,K.S., Wickramaarachchi,W.D., Wan,Q., Whang,I., Kim,E., Park,M.A., Park,H.C. and Lee,J. A C1 inhibitor ortholog from rock bream (Oplegnathus fasciatus): Molecular perspectives of a central regulator in terms of its genomic arrangement, transcriptional profiles and anti-protease activities of recombinant peptide Dev Comp Immunol (2014) 42, 197-210. PubMed Europe PubMed DOI

2013

Degn,S.E., Thiel,S. and Jensenius,J.C. Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor Protein Expr Purif (2013) 88, 173-182. PubMed Europe PubMed DOI E

2011

Caccia,S., Castelli,R., Maiocchi,D., Bergamaschini,L. and Cugno,M. Interaction of C1 inhibitor with thrombin on the endothelial surface Blood Coagul Fibrinolysis (2011) 22, 571-575. PubMed Europe PubMed DOI

2010

Davis,A.E., III, Lu,F. and Mejia,P. C1 inhibitor, a multi-functional serine protease inhibitor Thromb Haemost (2010) 104, 886-893. PubMed Europe PubMed DOI V
Gibson,J., Cree,A., Collins,A., Lotery,A. and Ennis,S. Determination of a gene and environment risk model for age-related macular degeneration Br J Ophthalmol (2010) 94, 1382-1387. PubMed Europe PubMed DOI M
Rossi,V., Bally,I., Ancelet,S., Xu,Y., Fremeaux-Bacchi,V., Vives,R.R., Sadir,R., Thielens,N. and Arlaud,G.J. Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding J Immunol (2010) 184, 4982-4989. PubMed Europe PubMed DOI E
Thorgersen,E.B., Ludviksen,J.K., Lambris,J.D., Sfyroera,G., Nielsen,E.W. and Mollnes,T.E. Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity Innate Immun (2010) 16, 254-264. PubMed Europe PubMed DOI

2009

Gurewich,V. and Pannell,R. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis Thromb Haemost (2009) 102, 279-286. PubMed Europe PubMed DOI
Murray-Rust,T.A., Kerr,F.K., Thomas,A.R., Wu,T., Yongqing,T., Ong,P.C., Quinsey,N.S., Whisstock,J.C., Wagenaar-Bos,I.C., Freeman,C. and Pike,R.N. Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1 Biochem J (2009) 422, 295-303. PubMed Europe PubMed DOI

2008

Davis,A.E., III, Mejia,P. and Lu,F. Biological activities of C1 inhibitor Mol Immunol (2008) 45, 4057-4063. PubMed Europe PubMed DOI PMC EPMC
Frank,M.M. and Jiang,H. New therapies for hereditary angioedema: disease outlook changes dramatically J Allergy Clin Immunol (2008) 121, 272-280. PubMed Europe PubMed DOI V
Wouters,D., Wagenaar-Bos,I., van Ham,M. and Zeerleder,S. C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor Expert Opin Biol Ther (2008) 8, 1225-1240. PubMed Europe PubMed DOI V U

2007

Beinrohr,L., Harmat,V., Dobo,J., Lorincz,Z., Gal,P. and Zavodszky,P. C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease J Biol Chem (2007) 282, 21100-21109. PubMed Europe PubMed DOI E M S
Davis,A.E., III, Cai,S. and Liu,D. C1 inhibitor: biologic activities that are independent of protease inhibition Immunobiology (2007) 212, 313-323. PubMed Europe PubMed DOI PMC EPMC V
Farkas,H., Jakab,L., Temesszentandrasi,G., Visy,B., Harmat,G., Fust,G., Szeplaki,G., Fekete,B., Karadi,I. and Varga,L. Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy J Allergy Clin Immunol (2007) 120, 941-947. PubMed Europe PubMed DOI V

2006

C1 Esterase Inhibitor (2006) PubMed Europe PubMed
[YEAR:22-8-2006]Fu,J., Lin,G., Wu,Z., Ceng,B., Wu,Y., Liang,G., Qin,G., Li,J., Chiu,I. and Liu,D. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury Biochem Biophys Res Commun (22-8-2006) 349, 504-512. PubMed Europe PubMed DOI

2005

[YEAR:15-5-2005]Cai,S., Dole,V.S., Bergmeier,W., Scafidi,J., Feng,H., Wagner,D.D. and Davis,A.E., III A direct role for C1 inhibitor in regulation of leukocyte adhesion J Immunol (15-5-2005) 174, 6462-6466. PubMed Europe PubMed
Cicardi,M., Zingale,L., Zanichelli,A., Pappalardo,E. and Cicardi,B. C1 inhibitor: molecular and clinical aspects Springer Semin Immunopathol (2005) 27, 286-298. PubMed Europe PubMed DOI V

2004

[YEAR:1-6-2004]Bos,I.G., Lubbers,Y.T., Eldering,E., Abrahams,J.P. and Hack,C.E. Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitor Biochim Biophys Acta (1-6-2004) 1699, 139-144. PubMed Europe PubMed DOI
Davis,A.E., III Biological effects of C1 inhibitor Drug News Perspect (2004) 17, 439-446. PubMed Europe PubMed DOI V
Ravindran,S., Grys,T.E., Welch,R.A., Schapira,M. and Patston,P.A. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor Thromb Haemost (2004) 92, 1277-1283. PubMed Europe PubMed DOI

2003

Cumming,S.A., Halsall,D.J., Ewan,P.W. and Lomas,D.A. The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema J Med Genet (2003) 40, e114-e114. PubMed Europe PubMed PMC EPMC

2002

Brown,E.W., Ravindran,S. and Patston,P.A. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism Blood Coagul Fibrinolysis (2002) 13, 711-714. PubMed Europe PubMed DOI
Lathem,W.W., Grys,T.E., Witowski,S.E., Torres,A.G., Kaper,J.B., Tarr,P.I. and Welch,R.A. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor Mol Microbiol (2002) 45, 277-288. PubMed Europe PubMed DOI

2001

[YEAR:1-8-2001]Zahedi,R., MacFarlane,R.C., Wisnieski,J.J. and Davis,A.E., III C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition J Immunol (1-8-2001) 167, 1500-1506. PubMed Europe PubMed

1998

[YEAR:15-10-1998]Heeb,M.J. and Espana,F. alpha2-Macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein Blood Cells Mol Dis (15-10-1998) 24, 412-419. PubMed Europe PubMed DOI

1995

Patston,P.A., Qi,M., Schifferli,J.A. and Schapira,M. The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor Toxicon (1995) 33, 53-61. PubMed Europe PubMed DOI

1993

Aulak,K.S., Davis,A.E., III, Donaldson,V.H. and Harrison,R.A. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers Protein Sci (1993) 2, 727-732. PubMed Europe PubMed DOI PMC EPMC
Davis,A.E., III, Aulak,K.S., Zahedi,K., Bissler,J.J. and Harrison,R.A. C1 inhibitor Methods Enzymol (1993) 223, 97-120. PubMed Europe PubMed DOI V
Suzuki,K. Protein C inhibitor Methods Enzymol (1993) 222, 385-399. PubMed Europe PubMed DOI V

1987

[YEAR:15-6-1987]Faulmann,E.L., Young,M. and Boyle,M.D. Inactivation of the proteolytic activity of mouse nerve growth factor by human C1(activated)-inhibitor J Immunol (15-6-1987) 138, 4336-4340. PubMed Europe PubMed

1986

Wiman,B. Human C1-inhibitor [ISSN:0-444-80763-2] (1986) , 477-488. V

1985

Donaldson,V.H., Harrison,R.A., Rosen,F.S., Bing,D.H., Kindness,G., Canar,J., Wagner,C.J. and Awad,S. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies J Clin Invest (1985) 75, 124-132. PubMed Europe PubMed DOI PMC EPMC
[YEAR:25-2-1985]Salvesen,G.S., Catanese,J.J., Kress,L.F. and Travis,J. Primary structure of the reactive site of human C1-inhibitor J Biol Chem (25-2-1985) 260, 2432-2436. PubMed Europe PubMed

1984

de Agostini,A., Lijnen,H.R., Pixley,R.A., Colman,R.W. and Schapira,M. Inactivation of factor XII active fragment in normal plasma. Predominant role of C1-inhibitor J Clin Invest (1984) 73, 1542-1549. PubMed Europe PubMed DOI PMC EPMC

1983

[YEAR:11-10-1983]Harrison,R.A. Human C1 inhibitor: improved isolation and preliminary structural characterization Biochemistry (11-10-1983) 22, 5001-5007. PubMed Europe PubMed
Nilsson,T. and Wiman,B. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s Eur J Biochem (1983) 129, 663-667. PubMed Europe PubMed
[YEAR:1-9-1983]Nilsson,T., Sjoholm,I. and Wiman,B. Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s Biochem J (1-9-1983) 213, 617-624. PubMed Europe PubMed PMC EPMC
[YEAR:14-3-1983]Wiman,B. and Nilsson,T. A new simple method for determination of C1-esterase inhibitor activity in plasma Clin Chim Acta (14-3-1983) 128, 359-366. PubMed Europe PubMed

1982

Caughman,G.B., Boackle,R.J. and Vesely,J. A postulated mechanism for heparin's potentiation of C1 inhibitor function Mol Immunol (1982) 19, 287-295. PubMed Europe PubMed DOI
[YEAR:1-1-1982]Chesne,S., Villiers,C.L., Arlaud,G.J., Lacroix,M.B. and Colomb,M.G. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1 Biochem J (1-1-1982) 201, 61-70. PubMed Europe PubMed PMC EPMC
[YEAR:26-7-1982]Nilsson,T. and Wiman,B. Purification and characterization of human C1-esterase inhibitor Biochim Biophys Acta (26-7-1982) 705, 271-276. PubMed Europe PubMed
Schapira,M., Silver,L.D., Scott,C.F. and Colman,R.W. New and rapid functional assay for C1 inhibitor in human plasma Blood (1982) 59, 719-724. PubMed Europe PubMed

1981

Sim,R.B. and Reboul,A. Preparation and properties of human C1úbarú inhibitor Methods Enzymol (1981) 80, 43-54. PubMed Europe PubMed DOI V

1980

[YEAR:11-4-1980]Sim,R.B., Arlaud,G.J. and Colomb,M.G. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s Biochim Biophys Acta (11-4-1980) 612, 433-449. PubMed Europe PubMed

1979

[YEAR:25-1-1979]Arlaud,G.J., Reboul,A., Sim,R.B. and Colomb,M.G. Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1 Biochim Biophys Acta (25-1-1979) 576, 151-162. PubMed Europe PubMed
[YEAR:1-1-1979]Sim,R.B., Reboul,A., Arlaud,G.J., Villiers,C.L. and Colomb,M.G. Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma FEBS Lett (1-1-1979) 97, 111-115. PubMed Europe PubMed DOI
[YEAR:1-6-1979]Sim,R.B., Arlaud,G.J. and Colomb,M.G. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes Biochem J (1-6-1979) 179, 449-457. PubMed Europe PubMed PMC EPMC

1977

[YEAR:1-7-1977]Reboul,A., Arlaud,G.J., Sim,R.B. and Colomb,M.G. A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s FEBS Lett (1-7-1977) 79, 45-50. PubMed Europe PubMed DOI

1976

Harpel,P.C. C1 inactivator Methods Enzymol (1976) 45, 751-750. PubMed Europe PubMed DOI V

1975

Harpel,P.C. and Cooper,N.R. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin J Clin Invest (1975) 55, 593-604. PubMed Europe PubMed DOI PMC EPMC
[YEAR:20-10-1975]Owen,W.G. Evidence for the formation of an ester between thrombin and heparin cofactor Biochim Biophys Acta (20-10-1975) 405, 380-387. PubMed Europe PubMed

1970

Forbes,C.D., Pensky,J. and Ratnoff,O.D. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator J Lab Clin Med (1970) 76, 809-815. PubMed Europe PubMed
Haupt,H., Heimburger,N., Kranz,T. and Schwick,H.G. [Isolation and characterization of C1-Inactivator from human plasma] Eur J Biochem (1970) 17, 254-261. PubMed Europe PubMed

1969

Ratnoff,O.D., Pensky,J., Ogston,D. and Naff,G.B. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor J Exp Med (1969) 129, 315-331. PubMed Europe PubMed PMC EPMC

1961

Pensky,J., Levy,L.R. and Lepow,I.H. Partial purification of a serum inhibitor of C'1-esterase J Biol Chem (1961) 236, 1674-1679. PubMed Europe PubMed